A-7 Statistical Report On FIP Applications And Cases Discontinued, February 2004

Monthly statistical report on FIP by Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, March 2004

Monthly statistical report on FIP by Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, May 2004

Monthly statistical report on FIP by the Iowa Department of Human Services

A8a Summary of Food Stamp Errors-Active and Negative cases, July 2004

A-8A summary of food stamp errors active and negative cases

African tick-bite fever: a new entity in the differential diagnosis of multiple eschars in travelers. Description of five cases imported from South Africa to Switzerland.

African tick-bite fever (ATBF) is a newly described spotted fever rickettsiosis that frequently presents with multiple eschars in travelers returning from sub-Saharan Africa and, to a lesser extent, from the West Indies. It is caused by the bite of an infected Amblyomma tick, whose hunting habits explain the typical presence of multiple inoculation skin lesions and the occurrence of clustered cases. The etiological agent of ATBF is Rickettsia africae, an emerging tick-borne pathogenic bacterium. We describe herein a cluster of five cases of ATBF occurring in Swiss travelers returning from South Africa. The co-incidental infections in these five patients and the presence of multiple inoculation eschars, two features pathognomonic of this rickettsial disease, suggested the diagnosis of ATBF. Indeed, the presence of at least one inoculation eschar is observed in 53-100% of cases and multiple eschars in 21-54%. Two patients presented regional lymphadenitis and one a mild local lymphangitis. Though a cutaneous rash is described in 15-46% of cases, no rash was observed in our series. ATBF was confirmed by serology. Thus, ATBF has recently emerged as one of the most important causes of flu-like illness in travelers returning from Southern Africa. The presence of one or multiple eschars of inoculation is an important clinical clue to the diagnosis. It can be confirmed by serology or by PCR of a biopsy of the eschar. Culture can also be done in reference laboratories. Dermatologists and primary care physicians should know this clinical entity, since an inexpensive and efficient treatment is available.

A-8a 2003 Summary of Food Stamp Errors - Active and Negative Cases, April 2001 - September 2001

Summary of food stamp errors.

A-7 Statistical Report On FIP Applications And Cases Discontinued, July 2002

Monthly statistical report on FIP by Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, September 2003

Monthly statistical report on FIP by Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, November 2001

Monthly statistical report on FIP by Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, January 2002

Monthly statistical report on FIP by Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, June 2004

Monthly statistical report on FIP by the Iowa Department of Human Services

A-7 Statistical Report On FIP Applications And Cases Discontinued, July 2004

Statistical Report On FIP Applications And Cases Discontinued

Risk Factors in Fatal Cases of Anaphylaxis due to Contrast Media: A Forensic Evaluation.

BACKGROUND: Fatalities following contrast medium exposure are extremely rare in clinical routine, though they may occur as an exception. Some may fall under the purview of the inquiring authorities and forensic pathologists due to their in-hospital occurrence. The purpose of this study was to assess the risk factors for anaphylaxis due to contrast medium administration that can be identified in fatal cases. METHODS: Fatalities occurred during the course of clinical investigations with contrast media described in the literature and fatal reactions to contrast agents that had undergone forensic investigations in our medicolegal center were reviewed with respect to patient characteristics, administered contrast medium, performed biochemical investigations and potential risk factors identified based on clinical history and medical records. RESULTS: Biochemical investigations into the fatal cases examined in our facility revealed increased mast cell tryptase, total IgE and activated mast cells in all subjects. Data obtained from the literature and our own investigations indicated that in only a minority of the fatal cases had there been previous exposure to contrast compounds, while most cases of severe anaphylaxis involved patients who apparently reacted on initial exposure. CONCLUSIONS: Most fatal cases failed to present any identifiable predisposing conditions out of those traditionally considered as risk factors for an anaphylactic reaction to contrast compounds in the medical histories of the patients. Comprehensive clinical histories and thorough reviews of medical data, along with exhaustive forensic investigations, provide information that is relevant in order to better appreciate the interwoven relationships linking all factors potentially involved in the pathogenesis of fatal anaphylaxis to contrast media. © 2014 S. Karger AG, Basel.

A-7 Statistical Report On FIP Applications And Cases Discontinued, August 2004

Statistical Report On FIP Applications And Cases Discontinued

A-7, Statistical Report On FIP Applications And Cases Discontinued, September 2004

Statistical Report On FIP Applications And Cases Discontinued